ZA837484B - Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor,useful for the treatment of myocardium infarction - Google Patents

Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor,useful for the treatment of myocardium infarction

Info

Publication number
ZA837484B
ZA837484B ZA837484A ZA837484A ZA837484B ZA 837484 B ZA837484 B ZA 837484B ZA 837484 A ZA837484 A ZA 837484A ZA 837484 A ZA837484 A ZA 837484A ZA 837484 B ZA837484 B ZA 837484B
Authority
ZA
South Africa
Prior art keywords
useful
treatment
pharmaceutical composition
composition containing
fibrinolytic agent
Prior art date
Application number
ZA837484A
Other languages
English (en)
Inventor
Francesco Borrelli
Francesco Antonetti
Original Assignee
Serono Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ist Farm filed Critical Serono Ist Farm
Publication of ZA837484B publication Critical patent/ZA837484B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA837484A 1982-10-08 1983-10-06 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor,useful for the treatment of myocardium infarction ZA837484B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico

Publications (1)

Publication Number Publication Date
ZA837484B true ZA837484B (en) 1984-06-27

Family

ID=11270058

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA837484A ZA837484B (en) 1982-10-08 1983-10-06 Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor,useful for the treatment of myocardium infarction

Country Status (12)

Country Link
US (1) US4568543A (it)
EP (1) EP0106812B1 (it)
JP (1) JPS5989630A (it)
AT (1) ATE44467T1 (it)
AU (1) AU559192B2 (it)
CA (1) CA1217717A (it)
DE (2) DE106812T1 (it)
DK (1) DK161564C (it)
ES (1) ES8704736A1 (it)
IL (1) IL69938A (it)
IT (1) IT1189379B (it)
ZA (1) ZA837484B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
EP0456724B1 (en) * 1989-01-27 1995-05-03 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
WO1996019221A1 (en) * 1994-12-22 1996-06-27 Smithkline Beecham Corporation Fibrinogen receptor antagonists
AU2003220115A1 (en) * 2002-05-20 2003-12-12 Board Of Regents, The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179787A (en) * 1967-03-22 1970-01-28 Biorex Laboratories Ltd Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) * 1979-03-07 1981-06-02 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration

Also Published As

Publication number Publication date
DE106812T1 (de) 1984-08-30
EP0106812B1 (en) 1989-07-12
AU559192B2 (en) 1987-02-26
IT8249241A0 (it) 1982-10-08
EP0106812A3 (en) 1985-09-11
IL69938A (en) 1987-09-16
ES526300A0 (es) 1987-05-01
CA1217717A (en) 1987-02-10
EP0106812A2 (en) 1984-04-25
ES8704736A1 (es) 1987-05-01
US4568543A (en) 1986-02-04
DK161564C (da) 1992-01-06
JPS6150927B2 (it) 1986-11-06
AU1988383A (en) 1984-04-12
DE3380166D1 (en) 1989-08-17
JPS5989630A (ja) 1984-05-23
DK464483A (da) 1984-04-09
IL69938A0 (en) 1984-01-31
ATE44467T1 (de) 1989-07-15
DK464483D0 (da) 1983-10-07
IT1189379B (it) 1988-02-04
DK161564B (da) 1991-07-22

Similar Documents

Publication Publication Date Title
MY101791A (en) New benzimidazole derivatives
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
DE3271990D1 (en) Therapeutically active compound and pharmaceutical composition containing the same
EG18379A (en) Novel pharmacological compounds
PT76831B (en) Process for preparing teichomycin a2 pure single factors 1,2,3,4 and 5 and of pharmaceutical compositions containing the same
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
IL69381A (en) Azetidine compounds and pharmaceutical compositions containing the same
DE3380166D1 (en) Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
ES8701491A1 (es) Procedimiento para la preparacion de substancias secas obte-nibles por liofilizacion
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
GB1483650A (en) Pharmaceutical preparations based on mesterolone
IL58576A0 (en) 2-substituted and 2,6 disubstituted penem compounds their preparation and pharmaceutical compositions containing them
HUT38353A (en) Process for producing 7-oxo-4-thia-1-azabicyclo/3.2.0/hept-2-ene derivatives and pharmaceutical compositions containing them as active agents
PT80214B (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
ZA776142B (en) Biologically active tricyclic compounds and pharmaceutical compositions containing same
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
CA2122478A1 (en) Unit Dose Form of Bismuth Subsalicylate
GB1449441A (en) Agnets for lowering the lipid level in plasma
HUT37764A (en) Process for producing 1,4-dihydro-pyrazines and pharmaceutical compositions containing them as active agents
ZA85106B (en) Tricyclic compounds,processes for their preparation,composition containing such compounds and their use in medicine